Les CFD sont des instruments complexes et sont accompagnés d’un risque élevé de pertes financières rapides en raison de l’effet de levier. 74 % des comptes d’investisseurs particuliers perdent de l’argent en tradant des CFD avec ce fournisseur. Vous devez déterminer si vous comprenez comment fonctionnent les CFD et si vous pouvez vous permettre de courir le risque élevé de perdre votre argent.

Close

Tradez Gilead GILD

Vendre
 Acheter

 Graphique en direct de Gilead

5m 15m 30m 1h 4h 1d 1w

Principes de base des instruments

Weekly Search
Weekly
Daily
Date Fermer Changes % Variation Ouvrir un compte Haut Bas

Dernières nouvelles

Closing 2024
2024 Dec 26, 17:00

Semaine à venir : Clôture de l’année 2024 et premières données économiques de 2025

UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Semaine à venir : Dernière semaine complète de 2024 sur les marchés financiers

Le Forex Indices
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Semaine à venir : Les taux d'intérêt américains et l'inflation en Europe déterminent l'orientation des marchés

Indices Le Forex
Dyogenes Diniz 2024 Dec 05, 16:00

Semaine à venir : L'inflation et les taux d'intérêt vont secouer les marchés cette semaine

Le Forex Indices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Semaine à venir :  L'emploi aux États-Unis devrait influencer le sentiment des marchés cette semaine.

Le Forex Indices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Semaine à venir : L'inflation de la zone euro devrait confirmer une réduction des taux de la BCE en décembre

Le Forex Indices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Semaine à venir : La hausse de la tech table sur les résultats de Nvidia

Le Forex Indices
Markets.com Support Team 2024 Nov 07, 16:00

Semaine à venir : « Trump trade », données sur l'inflation, résultats de Disney

Le Forex Indices

Info

Spread

0.67

Spread (%)

0.6310 %

Effet de levier

1:5

Intérêt au jour le jour à l’achat

-0.0597 %

Intérêt au jour le jour à la vente

-0.0292 %

Devise

USD

Horaires de Trading

Markets closed

Mardi

13:31 - 19:59

Lundi

13:31-19:59

Mercredi

13:31-19:59

Jeudi

13:31-19:59

Vendredi

13:31-19:59

Analyse et statistiques

Ouvrir un compte

---

Fermeture précédente

---

Plus haut/plus bas des 52 dernières semaines

--- – ---

Capitalisation boursière

132766097408

Actions en circulation

1246630016

Date de rapport d'activité (suivante)

2013-01-28

Rendement des div

2025-03-28

Date de détachement du dividende

2025-03-14

Le taux de dividende annuel à terme 

3.16

Le rendement de dividende annuel à terme

0.0305

EPS

0.39

En savoir plus sur cet instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Instruments connexes

Actif
Vendre
Acheter
% Variation

Tradez

Tradez

Tradez

Tradez
Instruments connexes
Trustpilot
RequestMessages5TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version46.78msRequest Duration2MBMemory UsageGET csrf
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
controller_action
Closure
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
action_name
controller_action
Closure
uri
GET csrf
file
routes/web.php:26-30
middleware
web
duration
48.45ms
peak_memory
2MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktloc=eyJpdiI6IjFhcjFYbFVxTmlqbG8yZmNSa0dFSWc9PSIsInZhbHVlIjoiVWpNSjBjOXplTVlqRi9QakZ5eDFRRWlWSjVFeDRZa2VqS3k2alMwaDNXSWJMa0cyNzRnM256dnpERk5rK1J0cyIsIm1hYyI6ImU0YzA1YTUyNjZjNjgwMTUxOTNiMTJkYzRhMzM0YjU1YTEyZTEwNjA4Y2U5MWFkYjcwNTA0ZGMyNjk5ZWI5NTQiLCJ0YWciOiIifQ%3D%3D; firstURL=https://web-qa.staging.markets.com/hi/instrument/eurjpy/; lastURL=https://web-qa.staging.markets.com/hi/instrument/eurjpy/; mktv4_ip_override=fr; intent_group=%252Ffr%252Finstrument%252Fgilead%252F; intent_instrument=gilead; XSRF-TOKEN=eyJpdiI6IkVGdE9IR2twQU9VRERxUUsyQ2pSL3c9PSIsInZhbHVlIjoiVkdISzJ1YWtOWFlRVVI2WUozRXhXeWF2ejRkMUZJV2prdnM5VTBZaUZVSEhBV2xwb2dJai9OSUNFcUxVVjhwdmtRd1ByZHlDbld2M3F1WW5ydW53SHJST2dqSXJzQ1g1OXArZkw1aTdZL3RINFJ3R1BuZ1Zjb1ZnRklMZTlBbDQiLCJtYWMiOiJhY2QyYzg4ZmI1ODJlZWFhMmUyYTQwNzg1ZmIwNmI1OWI1Y2QxODc1YTQyM2IwMWUxNzA3ODc5NzhkMmJkMzE0IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6IlVwaXNpQlEyRTV6NjczaytMZ3drc1E9PSIsInZhbHVlIjoiVzhzd1VabGtGMm1nNE1HNlpzR1hET2h5VmlkR1RKU2xkamJRSWZiN1RmMU5GZzdHMzNUa2JERmQ3Z3d1VlovL1RKMHpQZWtIVlJWWmk1R0FvWWx0dEVNV1NCWVZuQWpraGJHN1FVcUF5S2ZDSDRzMWoyVkFoNVp0Yzg5dnlTb20iLCJtYWMiOiIxOWEzYTZkOGFiMjY1ZGNmZTBjODk1NzRlNmQ3ZDQ5OWYyYTJjM2I2MWJhODFkZGUwODhiMmFkNWY1Yzc3ODk4IiwidGFnIjoiIn0%3D ◀mktloc=eyJpdiI6IjFhcjFYbFVxTmlqbG8yZmNSa0dFSWc9PSIsInZhbHVlIjoiVWpNSjBjOXplTVlqRi9QakZ5eDFRRWlWSjVFeDRZa2VqS3k2alMwaDNXSWJMa0cyNzRnM256dnpERk5rK1J0cyIsIm1hYyI6I ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktloc" => "us,us"
  "firstURL" => null
  "lastURL" => null
  "mktv4_ip_override" => null
  "intent_group" => null
  "intent_instrument" => null
  "XSRF-TOKEN" => "XLFg4b6Z7vGHW4Bi2FDikLJ6HtH4dq6KY266Ajix"
  "laravel_session" => "DVvYw1UkK3MOgMFbNGWReQrHiizozk9wgVnvZfJm"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Wed, 16 Apr 2025 01:19:40 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "XLFg4b6Z7vGHW4Bi2FDikLJ6HtH4dq6KY266Ajix"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/fr/GILD:NASDAQ?scheme=light"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (33.59ms)time
    • Application (13.18ms)time
    • Routing (526μs)
    • 1 x Booting (71.81%)
      33.59ms
      1 x Application (28.17%)
      13.18ms
      1 x Routing (1.12%)
      526μs
      0 templates were rendered
        uri
        GET csrf
        middleware
        web
        uses
        Closure(Request $request) {#347 class: "Illuminate\Routing\RouteFileRegistrar" this: Illuminate\Routing\RouteFileRegistrar {#344 …} file: "/var/www/website/qa/laravel/routes/web.php" line: "26 to 30" }
        file
        routes/web.php:26-30
        0 statements were executed0μs
              _token
              XLFg4b6Z7vGHW4Bi2FDikLJ6HtH4dq6KY266Ajix
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/fr/GILD:NASDAQ?sc...
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-16 01:19:38GET/fr/instrument/gilead/567
              #22025-04-16 01:19:40GET/params/ (ajax)
              #32025-04-16 01:19:40GET/csrf/ (ajax)